Abstract:Objective The rising incidence of neonatal abstinence syndrome (NAS) has amplified the importance of nonpharmacological interventions in its management, which include the selection of feedings. With the goal of obtaining an accurate assessment of the effects of current feeding practices in NAS infants in our neonatal intensive care unit, we conducted a retrospective review of NAS infants at our hospital over a 3-year period to determine their nutritional selections and evaluate their length of stay (LOS), length of treatment (LOT), and growth outcomes. Study Design Retrospective chart review of term infants (≥37 weeks of gestation) with NAS. Maternal and infant demographics and characteristics were recorded. Infants were grouped based on majority (>50% of total feeding) nutritional selections and LOS, LOT, and growth parameters were evaluated. Linear regression was used to compare group outcomes. Significance was set at a p -value <0.05. Results A total of 70 infants were included and grouped based on majority feeds into maternal breast milk (MBM), standard term formula (STF), low lactose formula (LLF), and extensively hydrolyzed formula (EHF) groups. Feeding selections were provider-dependent and infants were placed on MBM or STF as an initial selection. In all infants included in our review, LLF was selected as the first choice following MBM or STF for increased gastrointestinal (GI) disturbance-related Finnegan Neonatal Abstinence Scoring scores and changed to EHF if LLF failed to improve the GI-related symptoms. The STF-fed infants had the shortest LOS, and none of these infants required pharmacological treatment. The LOT and LOS were similar in the MBM- and LLF-fed groups. Infants who were EHF fed had the longest LOT and LOS. All feeding groups demonstrated appropriate growth. Conclusion Nutritional selections in our NAS infants were modified for the severity of their withdrawal symptoms. All nutritional modifications driven by severity of withdrawal symptoms supported favorable growth outcomes in the infants. Key Points Our NAS infants were fed with multiple types of nutrition. Infants with severe NAS required more elemental feeds. All formula selections supported favorable growth. Received: 19 December 2023 Accepted: 17 September 2024 Article published online: 10 October 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review

Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment

Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

Current management of neonatal abstinence syndrome: a survey of practice in the UK and Ireland

Gut Microbiota and Symptom Expression and Severity in Neonatal Abstinence Syndrome

Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

HHS releases standard definition for opioid withdrawal in infants

Chapter 8: The Role of Genetics in Neonatal Abstinence Syndrome

Assessment of the Standardized Surveillance Case Definition for Neonatal Abstinence Syndrome by the Council of State and Territorial Epidemiologists, 4 Jurisdictions, 2020-2021

Neonatal Abstinence Syndrome and Corresponding Pharmacotherapy Approaches from 2 University-affiliated Neonatal Intensive Care Units in Puerto Rico (2018-2020)

Diagnosis Codes and Case Definitions for Neonatal Abstinence Syndrome

Evaluating Nutritional Selection and Outcomes in Neonatal Abstinence Syndrome: A Retrospective Review

Cost of neonatal abstinence syndrome: an economic analysis of English national data held in the National Neonatal Research Database

Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome

Development and Validation of a Model to Predict Neonatal Abstinence Syndrome

Eat, Sleep, Console Approach: A Family-Centered Model for the Treatment of Neonatal Abstinence Syndrome

Molecular and Long-Term Behavioral Consequences of Neonatal Opioid Exposure and Withdrawal in Mice.

Global research production in neonatal abstinence syndrome: A bibliometric analysis

Neonatal Abstinence Syndrome and High School Performance